Then we uncovered the main active compounds and mechanism of SSJZF against NAFLD by integrating RNA-sequencing and network pharmacology, and PI3K/AKT pathway activity was verified by western blot. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.